contact@iris-capinvest.com

Home
Who we are
News
Our Culture and values
What we offer
Our strengths
Contact

THERANEXUS raises around 3.1 million euros in fundraising

July 13, 2023

Lyon, Jul 13, 2023 – THERANEXUS raises around 3.1 million euros in fundraising

DOWNLOAD THERANEXUS press release

Share

Previous Post ABIONYX Pharma accelerates its development by launching a new biomanufacturing campaign based

Next Post TheraVet announces the setting up of an equity-linked financing facility and updates on its financing strategy

Search

Recent News

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE AN AGREEMENT LICENSE FOR THE MARKETING OF THERANEXUS TX01 IN THE TREATMENT OF TWO RARE NEUROLOGICAL DISEASES

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE AN AGREEMENT LICENSE FOR THE MARKETING OF THERANEXUS TX01 IN THE TREATMENT OF TWO RARE NEUROLOGICAL DISEASES

December 17, 2024

Establishment of a renewable equity financing line of a maximum amount of €2 million to support the ramp-up of the Revin industrial site

Establishment of a renewable equity financing line of a maximum amount of €2 million to support the ramp-up of the Revin industrial site

October 16, 2024

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG Royalties for USD 50 million

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG Royalties for USD 50 million

September 30, 2024

Recents news

2024
2023
2022
2021
2020
2019

5 Villa Houssay 92200 Neuilly sur Seine

Contact us

5 Villa Houssay 92200 Neuilly sur Seine France
contact@iris-capinvest.com

Links

Home
News
Contact
Privacy Policy
Cookie Policy
Legal

2020 © All rights reserved by IRIS CAPITAL INVESTMENT

2024